Stocks · Health care · Pharmaceutical Preparations

RHYTHM PHARMACEUTICALS, INC.

RYTM Clue Score45
United States Fiscal year ends December CIK 0001649904 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Hunter C Smith
18 May 2026
Chief Financial Officer
Exercised, kept
3,000
$17.87
$53.61K
Hunter C Smith
2 Mar 2026
Chief Financial Officer
Exercised, kept
6,099
$6.80
$41.47K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 23
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 586,248
History held since 6 Oct 2017